title: Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients.
authors.affiliation: Transplant Unit, University Hospital, Uppsala, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Wahlberg
authors.forename: E
authors.initials: E
authors.lastname: Hanås
authors.forename: C
authors.initials: C
authors.lastname: Bergström
authors.forename: B
authors.initials: B
authors.lastname: Fellström
authors.forename: I
authors.initials: I
authors.lastname: Skarp-Orberg
authors.forename: L
authors.initials: L
authors.lastname: Frödin
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage / Q000627:therapeutic use; D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D004110:Diltiazem / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011446:Prospective Studies
chemical_list: D016572:Cyclosporine; D011239:Prednisolone; D003404:Creatinine; D004110:Diltiazem; D001379:Azathioprine